Related Experiment Video
Updated: May 5, 2026
05:08
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
4.3K
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects
Edouard Bardou-Jacquet1, Zeineb Ben Ali2, Marie-Pascale Beaumont-Epinette3
1University Hospital of Rennes, French reference center for rare iron overload diseases of genetic origin, Rennes, France; University of Rennes1, Inserm UMR 991, 35000 Rennes, France; University Hospital of Rennes, Liver disease department, Rennes, France.
Clinics and Research in Hepatology and Gastroenterology
|December 11, 2013
Summary
Advances in genetics have identified four types of hemochromatosis, rare genetic iron overload diseases. Diagnosis requires understanding physiological defects and utilizing biological and imaging tools for management.
Area of Science:
- Genetics
- Molecular Biology
- Iron Metabolism
Background:
- Genetic iron overload diseases, particularly hereditary hemochromatosis, are increasingly understood.
- Classical type 1 hemochromatosis is linked to the HFE C282Y mutation.
- Recent discoveries have expanded the classification beyond HFE-related forms.
Purpose of the Study:
- To outline the current understanding of rare genetic iron overload diseases.
- To detail the different identified types of hemochromatosis.
- To emphasize the diagnostic and management approaches for these conditions.
Main Methods:
- Review of genetic and molecular biology advances in iron metabolism.
- Identification and classification of known hemochromatosis types.
- Discussion of diagnostic tools for assessing iron metabolism.
Main Results:
- Four main types of hemochromatosis are now recognized: HFE-related (type 1) and rare types 2, 3, and 4.
- Type 2 involves hemojuvelin/hepcidin mutations (juvenile hemochromatosis).
- Type 3 is associated with transferrin receptor 2 mutations, and type 4 with ferroportin disease.
Conclusions:
- Understanding the specific physiological defect is crucial for diagnosing rare iron overload disorders.
- Biological and imaging tools enable non-invasive assessment of iron metabolism.
- A multidisciplinary approach is vital for effective diagnosis and patient management.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:25Jaundice
35
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
35
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:22Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271